These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15943557)

  • 1. Preconception cystic fibrosis carrier screening: costs and consequences.
    Weijers-Poppelaars FA; Wildhagen MF; Henneman L; Cornel MC; Kate LP
    Genet Test; 2005; 9(2):158-66. PubMed ID: 15943557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preconception screening of parents and carrier state of cystic fibrosis in the Netherlands: expenses and savings].
    Verheij JB; Hilderink HB; Verzijl JG; Wildhagen MF; Habbema JD; ten Kate LP
    Ned Tijdschr Geneeskd; 1998 Mar; 142(13):706-10. PubMed ID: 9623144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost-effectiveness of prenatal carrier screening for cystic fibrosis.
    Lieu TA; Watson SE; Washington AE
    Obstet Gynecol; 1994 Dec; 84(6):903-12. PubMed ID: 7970468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carrier screening for cystic fibrosis: costs and clinical outcomes.
    Asch DA; Hershey JC; Dekay ML; Pauly MV; Patton JP; Jedrziewski MK; Frei F; Giardine R; Kant JA; Mennuti MT
    Med Decis Making; 1998; 18(2):202-12. PubMed ID: 9566453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on population-based preconception and prenatal cystic fibrosis carrier screening.
    Nolen AA; Rhoades ED
    J Okla State Med Assoc; 2003 Oct; 96(10):482-4. PubMed ID: 14619603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Informing policy for the Australian context - Costs, outcomes and cost savings of prenatal carrier screening for cystic fibrosis.
    Maxwell S; Brameld K; Youngs L; Geelhoed E; O'Leary P
    Aust N Z J Obstet Gynaecol; 2010 Feb; 50(1):51-9. PubMed ID: 20218998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Offering preconceptional cystic fibrosis carrier couple screening in the absence of established preconceptional care services.
    Henneman L; Bramsen I; van Kempen L; van Acker MB; Pals G; van der Horst HE; Adèr HJ; van der Ploeg HM; ten Kate LP
    Community Genet; 2003; 6(1):5-13. PubMed ID: 12748433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs, effects, and savings of screening for cystic fibrosis gene carriers.
    Wildhagen MF; Hilderink HB; Verzijl JG; Verheij JB; Kooij L; Tijmstra T; ten Kate LP; Habbema JD
    J Epidemiol Community Health; 1998 Jul; 52(7):459-67. PubMed ID: 9799881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal and preconception population carrier screening for cystic fibrosis in Australia: where are we up to?
    Massie J; Ioannou L; Delatycki M
    Aust N Z J Obstet Gynaecol; 2014 Dec; 54(6):503-9. PubMed ID: 25350764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of carrier screening for cystic fibrosis in Australia.
    Norman R; van Gool K; Hall J; Delatycki M; Massie J
    J Cyst Fibros; 2012 Jul; 11(4):281-7. PubMed ID: 22425241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cost-effectiveness analysis of prenatal carrier screening for cystic fibrosis.
    Vintzileos AM; Ananth CV; Smulian JC; Fisher AJ; Day-Salvatore D; Beazoglou T
    Obstet Gynecol; 1998 Apr; 91(4):529-34. PubMed ID: 9540935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community-wide screening for cystic fibrosis carriers could replace newborn screening for the diagnosis of cystic fibrosis.
    Massie J; Forbes R; Dusart D; Bankier A; Delatycki MB
    J Paediatr Child Health; 2007 Nov; 43(11):721-3. PubMed ID: 17924936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preconception cystic fibrosis carrier couple screening: impact, understanding, and satisfaction.
    Henneman L; Bramsen I; van der Ploeg HM; ten Kate LP
    Genet Test; 2002; 6(3):195-202. PubMed ID: 12490059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost comparison of different methods of screening for cystic fibrosis.
    Morris JK; Oppenheimer PM
    J Med Screen; 1995; 2(1):22-7. PubMed ID: 7497140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preconceptional screening of couples for carriers of cystic fibrosis: a prospective evaluation of effects, costs and savings for different mutation detection methods.
    Verheij JB; Wildhagen MF; Hofstra RM; Pals G; Habbema JD; ten Kate LP
    Community Genet; 1999; 2(2-3):74-81. PubMed ID: 15181337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preconception screening for carrier state in cystic fibrosis; testing against Health Council's criteria for genetic screening].
    van de Laar J; ten Kate LP
    Ned Tijdschr Geneeskd; 1996 Mar; 140(9):487-91. PubMed ID: 8628436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Planning the development of cystic fibrosis gene carrier screening.
    Beech R; Bekker H
    J Health Serv Res Policy; 1996 Apr; 1(2):81-92. PubMed ID: 10180854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possibilities and barriers in the implementation of a preconceptional screening programme for cystic fibrosis carriers: a focus group study.
    Poppelaars FA; van der Wal G; Braspenning JC; Cornel MC; Henneman L; Langendam MW; ten Kate LP
    Public Health; 2003 Nov; 117(6):396-403. PubMed ID: 14522154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carrier screening for cystic fibrosis in US genetic testing laboratories: a survey of laboratory directors.
    Kaufman DJ; Katsanis SH; Javitt GH; Murphy JA; Scott JA; Hudson KL
    Clin Genet; 2008 Oct; 74(4):367-73. PubMed ID: 18700896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the potential success of cystic fibrosis carrier screening: lessons learned from Tay-Sachs disease and beta-thalassemia.
    Laberge AM; Watts C; Porter K; Burke W
    Public Health Genomics; 2010; 13(5):310-9. PubMed ID: 19864874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.